A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)

PHASE3CompletedINTERVENTIONAL

Enrollment

678

Participants

Timeline

Start Date

February 9, 2015

Primary Completion Date

July 30, 2016

Study Completion Date

July 30, 2016

Conditions

Alcohol Dependence

Interventions

DRUG

Nalmefene hydrochloride

As-needed; tablets, orally

DRUG

Placebo

As-needed; tablets, orally

Trial Locations (7)

Chubu, Region

Hokkaido, Region

Kanto, Region

Kinki, Region

Kyusyu, Region

Tohoku, Region

Tyugoku, Region